| ACLF | acute-on-chronic liver failure |
| AH | alcohol-associated hepatitis |
| ALD | alcohol-associated liver disease |
| ALP | alkaline phosphatase |
| ALT | alanine aminotransferase |
| AST | aspartate aminotransferase |
| ATP | adenosine triphosphate |
| AUC | area under the receiver-operating-characteristic curve |
| AUDIT-C | Alcohol Use Disorders Identification Test–Consumption |
| BH | Benjamini–Hochberg (procedure) |
| CBC | complete blood count |
| CCL2 | C-C motif chemokine ligand 2 |
| CCL17 | C-C motif chemokine ligand 17 |
| CCL20 | C-C motif chemokine ligand 20 |
| CCL22 | C-C motif chemokine ligand 22 |
| CCR2 | C-C chemokine receptor type 2 |
| CCR4 | C-C chemokine receptor type 4 |
| CCR6 | C-C chemokine receptor type 6 |
| CD14 | cluster of differentiation 14 |
| CI | confidence interval |
| COVID-19 | coronavirus disease 2019 |
| CRP | C-reactive protein |
| CTP | Child–Turcotte–Pugh (score) |
| CXCL9 | C-X-C motif chemokine ligand 9 |
| CXCL10 | C-X-C motif chemokine ligand 10 |
| CXCL16 | C-X-C motif chemokine ligand 16 |
| DAMP | damage-associated molecular pattern |
| DC | dendritic cell |
| ELISA | enzyme-linked immunosorbent assay |
| FIB-4 | Fibrosis-4 index |
| Foxp3 | Forkhead box P3 |
| GGT | gamma-glutamyl transferase |
| HCC | hepatocellular carcinoma |
| HCV | hepatitis C virus |
| HIV | human immunodeficiency virus |
| HMGB1 | high-mobility group box 1 |
| HSC | hepatic stellate cell |
| IL-8 | interleukin-8 |
| IL-17 | interleukin-17 |
| INR | international normalised ratio |
| IQR | interquartile range |
| KW | Kruskal–Wallis (test) |
| LCN2 | lipocalin-2 |
| LPS | lipopolysaccharide |
| LSEC | liver sinusoidal endothelial cell |
| Ly-6C | lymphocyte antigen 6C |
| LYMF | lymphocyte count |
| MASLD | metabolic dysfunction-associated steatotic liver disease |
| MCP-1 | monocyte chemoattractant protein-1 |
| mDF | modified Maddrey discriminant function |
| MELD | Model for End-Stage Liver Disease |
| MELD 3.0 | Model for End-Stage Liver Disease 3.0 |
| MELD-Na | Model for End-Stage Liver Disease–Sodium |
| METAVIR | meta-analysis of histological data in viral hepatitis (fibrosis staging system) |
| MIP-3α | macrophage inflammatory protein-3 alpha |
| NADPH | nicotinamide adenine dinucleotide phosphate |
| NAFLD | non-alcoholic fatty liver disease |
| NEU | neutrophil count |
| NF-κB | nuclear factor kappa B |
| NKT | natural killer T (cell) |
| NLR | neutrophil-to-lymphocyte ratio |
| NLRP3 | NLR family pyrin domain containing 3 |
| NOX4 | NADPH oxidase 4 |
| PAMP | pathogen-associated molecular pattern |
| PMN | polymorphonuclear |
| ROC | receiver operating characteristic |
| ROS | reactive oxygen species |
| SAM | scar-associated macrophage |
| SBP | spontaneous bacterial peritonitis |
| SII | systemic immune-inflammation index |
| STOPAH | steroids or pentoxifylline for alcoholic hepatitis (trial) |
| TARC | thymus and activation-regulated chemokine |
| Th1 | T helper 1 (cell) |
| Th2 | T helper 2 (cell) |
| Th17 | T helper 17 (cell) |
| TLR4 | Toll-like receptor 4 |
| Treg | regulatory T (cell) |
| WBC | white blood cell |
| ε2 | epsilon-squared (Kruskal–Wallis effect size) |